Pentavalent Meningococcal Vaccine Among Latest EU Filings

Marketing applications for MenABCWY, zolbetuximab, crovalimab, macitentan/tadalafil, Coacillium, mRNA-1345, dasiglucagon and ustekinumab have been submitted to the European Medicines Agency for review.

EU marketing applications for new medicines have started the review process • Source: Shutterstock

The European Medicines Agency has begun reviewing EU marketing authorization applications (MAAs) for a new batch of medicines, including one for MenABCWY, Pfizer’s investigational pentavalent meningococcal vaccine, which, if approved, could provide the broadest serogroup coverage of any meningococcal vaccine.

MenABCWY, according to Pfizer, could also help simplify the meningococcal vaccination schedule. By combining the components from the company’s two...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Product Reviews

More from Pink Sheet